BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36530401)

  • 1. Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study.
    Tang Z; Xu W; Zhang M
    PeerJ; 2022; 10():e14538. PubMed ID: 36530401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
    Pretta A; Ziranu P; Puzzoni M; Lai E; Orsi G; Liscia N; Molinaro E; Mariani S; Riggi L; Rovesti G; Dubois M; Migliari M; Persano M; Saba G; Impera V; Musio F; Batzella E; Demurtas L; Pusceddu V; Astara G; Faloppi L; Casadei Gardini A; Andrikou K; Cascinu S; Scartozzi M
    Tumori; 2021 Dec; 107(6):550-555. PubMed ID: 33243068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus.
    Nagpal SJS; Kandlakunta H; Her T; Sharma A; Sannapaneni S; Smyrk TC; Velamala P; Garg SK; Rakshit K; Majumder S; Chari S; Matveyenko A
    Pancreatology; 2020 Jul; 20(5):929-935. PubMed ID: 32620407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer.
    Zhang M; Hu X; Kang Y; Xu W; Yang X
    BMC Cancer; 2021 Feb; 21(1):131. PubMed ID: 33549043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
    Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
    Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
    JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes.
    Yoon BH; Ang SM; Alabd A; Furlong K; Yeo CJ; Lavu H; Winter JM
    J Surg Res; 2021 May; 261():215-225. PubMed ID: 33453685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China.
    Zhang PH; Chen ZW; Lv D; Xu YY; Gu WL; Zhang XH; Le YL; Zhu HH; Zhu YM
    BMC Public Health; 2012 Jul; 12():567. PubMed ID: 22839452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of stage iv colorectal cancer patients after primary surgery: a propensity score matching analysis.
    Liu XR; Liu F; Li ZW; Liu XY; Zhang W; Peng D
    Int J Colorectal Dis; 2023 Jun; 38(1):171. PubMed ID: 37330453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Molina-Montes E; Coscia C; Gómez-Rubio P; Fernández A; Boenink R; Rava M; Márquez M; Molero X; Löhr M; Sharp L; Michalski CW; Farré A; Perea J; O'Rorke M; Greenhalf W; Iglesias M; Tardón A; Gress TM; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Dominguez-Muñoz JE; Renz H; Balcells J; Costello E; Ilzarbe L; Kleeff J; Kong B; Mora J; O'Driscoll D; Poves I; Scarpa A; Yu J; Hidalgo M; Lawlor RT; Ye W; Carrato A; Real FX; Malats N;
    Gut; 2021 Feb; 70(2):319-329. PubMed ID: 32409590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study.
    Hwang A; Narayan V; Yang YX
    Cancer; 2013 Jan; 119(2):404-10. PubMed ID: 23292900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma.
    Vavallo A; Simone S; Lucarelli G; Rutigliano M; Galleggiante V; Grandaliano G; Gesualdo L; Campagna M; Cariello M; Ranieri E; Pertosa G; Lastilla G; Selvaggi FP; Ditonno P; Battaglia M
    Medicine (Baltimore); 2014 Dec; 93(27):e183. PubMed ID: 25501064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus.
    Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Langenbecks Arch Surg; 2020 May; 405(3):313-324. PubMed ID: 32367394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM
    JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
    Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
    Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset pancreatic cancer: a population-based study using the SEER registry.
    Ansari D; Althini C; Ohlsson H; Andersson R
    Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.
    Oberaigner W; Ebenbichler C; Oberaigner K; Juchum M; Schönherr HR; Lechleitner M
    BMC Public Health; 2014 Oct; 14():1058. PubMed ID: 25300498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of type 2 diabetes mellitus and risk of pancreatic cancer.
    Olakowska E; Olakowski M
    Endokrynol Pol; 2021; 72(4):395-401. PubMed ID: 34410681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.
    Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L
    Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.